Skip to main content
. 2017 Jul 7;20(3):332–342. doi: 10.1093/neuonc/nox129

Fig. 6.

Fig. 6

Transcriptomic profiling classifies shCdkn2a-PDGFB-T2A-CreERT2 induced tumors as proneural GBM. (A) Heatmap showing the subtype signature classification by TCGA (classification bar on top) and validation correlation scores of primary human GBM tumors using Spearman correlation. (B) Heatmap of 8 independent tumor samples from shCdkn2a-PDGFB-T2A-CreERT2 GBM shows an enrichment of a proneural signature using the same method as (A).